GoodRx Holdings (GDRX) Change in Accured Expenses (2019 - 2026)
GoodRx Holdings' Change in Accured Expenses history spans 7 years, with the latest figure at $1.2 million for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 87.35% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 79.96% decrease, with the full-year FY2025 number at $2.0 million, down 79.96% from a year prior.
- Change in Accured Expenses hit $1.2 million in Q4 2025 for GoodRx Holdings, down from $4.0 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for GDRX hit a ceiling of $18.0 million in Q2 2023 and a floor of -$25.2 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged $341600.0 across 5 years, with a median of $664500.0 in 2023.
- The widest YoY moves for Change in Accured Expenses: up 925.57% in 2022, down 25567.16% in 2022.
- Tracing GDRX's Change in Accured Expenses over 5 years: stood at -$1.2 million in 2021, then crashed by 524.9% to -$7.8 million in 2022, then tumbled by 222.32% to -$25.2 million in 2023, then soared by 137.01% to $9.3 million in 2024, then plummeted by 87.35% to $1.2 million in 2025.
- Business Quant data shows Change in Accured Expenses for GDRX at $1.2 million in Q4 2025, $4.0 million in Q3 2025, and -$3.4 million in Q2 2025.